Janelle Schrag, MPH

Director of Research Projects
Whitman-Walker Institute
Washington, District of Columbia, United States

Disclosure information not submitted.

Presentation(s):

• 577 - Acceptability, Feasibility and Appropriateness of the Mobile Outreach Retention and Engagement (MORE) Program and Home Long-Acting Cabotegravir/Rilpivirine (CAB+RPV LA) Injections for People with HIV (PWH) Experiencing Adherence Challenges at Whitman-Walker Health in Washington D.C.

  Wednesday, October 22, 2025
  11:30 AM - 11:43 AM US ET